ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced liver cancer: drug trial targets patients with limited options
Disease control Not yet recruitingThis phase 2 trial tests the drug lenvatinib as a first treatment for 50 adults with advanced liver cancer (HCC) who cannot have surgery or other curative treatments. The goal is to see if lenvatinib can control the cancer and improve survival. Participants must have measurable t…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New injection SZ1003 tested in Last-Resort liver cancer patients
Disease control Not yet recruitingThis early-stage trial will test the safety and tolerability of a new drug called SZ1003 in 12 adults with advanced hepatocellular carcinoma who have already tried and failed at least two standard treatments. Participants receive the drug by infusion every two weeks, and research…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC